MAST4 Antibody

What is MAST4 and what are its primary biological functions?

MAST4 (Microtubule Associated Serine/Threonine Kinase 4) is a 2,626 amino acid protein that functions as a serine/threonine kinase. It localizes primarily to the cytoplasm and contains one protein kinase domain, one PDZ domain, and one AGC-kinase C-terminal domain . Recent research has revealed that MAST4 plays critical roles in:

• Ciliary resorption through phosphorylation of Tctex-1, specifically at residue T94

• Regulation of mesenchymal stromal cell (MSC) differentiation into bone and cartilage lineages

• Modulation of TGF-β and Wnt signal transduction pathways

MAST4 uses magnesium as a cofactor to catalyze ATP-dependent phosphorylation of target proteins and is expressed at high levels in most adult tissues, including testis, colon, and small intestine .

What applications are MAST4 antibodies typically validated for?

Commercial MAST4 antibodies have been validated for multiple research applications:

These applications have been verified with specific optimization parameters depending on the antibody source and target species .

What is the predicted molecular weight of MAST4 and why might observed weights differ?

The calculated molecular weight of MAST4 is approximately 284 kDa , but researchers often observe bands at different molecular weights:

• Some commercial antibodies report observed weights of approximately 72 kDa

• Multiple isoforms exist due to alternative splicing events

When characterizing a new MAST4 antibody, researchers should be aware that discrepancies between calculated and observed molecular weights may be due to:

• Post-translational modifications

• Proteolytic processing

• Splice variants

• Antibody specificity for specific domains/regions

How should researchers optimize immunostaining protocols for MAST4 detection?

For optimal MAST4 detection in immunohistochemistry and immunocytochemistry:

For IHC-Paraffin sections:

• HIER (Heat-Induced Epitope Retrieval) at pH 6.0 is recommended

• Antibody dilutions typically range from 1:50 to 1:200

• Expected staining pattern: Strong cytoplasmic positivity in cells expressing MAST4, as shown in human esophagus where squamous epithelial cells display clear cytoplasmic reactivity

For Immunofluorescence:

• Fixation with PFA (paraformaldehyde) followed by permeabilization with Triton X-100

• Working concentrations of 0.25-2 μg/ml have been validated

• MAST4 typically shows localization to nucleoplasm and cytosol, as demonstrated in the human A-431 cell line

Critical parameters to monitor:

• Background staining levels

• Signal-to-noise ratio

• Specificity controls (blocking peptides or MAST4-depleted cells)

What experimental approaches can be used to study MAST4's role in ciliary resorption?

Based on published methodologies , researchers investigating MAST4's function in ciliary resorption should consider:

• Knockdown/knockout approaches:

  • siRNA targeting MAST4

  • CRISPR/Cas9-mediated gene editing

  • Expression of catalytic-inactive MAST4 mutants

• Phosphorylation analysis:

  • Monitor phosphorylation of Tctex-1 at T94, a key target of MAST4

  • Use phospho-specific antibodies for western blotting or immunofluorescence

• Ciliary resorption assays:

  • Track ciliary resorption kinetics following serum readdition to serum-starved cells

  • Analyze percentage of ciliated cells at multiple time points (30 min, 1h, 2h, 24h)

  • Compare wild-type cells with MAST4-depleted or MAST4-mutant cells

• Protein interaction studies:

  • Co-immunoprecipitation to confirm MAST4 binding to Tctex-1

  • Investigate MAST4's role in Cdc42 activation and Rab5-mediated periciliary membrane endocytosis

Research has demonstrated that MAST4 knockdown or expression of catalytic-inactive MAST4 mutants (particularly MAST4 R503A and MAST4 D504A) block ciliary resorption and reduce phospho-(T94)Tctex-1 localization at the ciliary base .

How can MAST4 antibodies be used to investigate mesenchymal stromal cell differentiation?

To study MAST4's role in MSC differentiation, researchers should consider the following experimental approaches based on published work :

• Differential expression analysis:

  • Monitor MAST4 expression levels during chondrogenic differentiation using western blotting

  • Track correlation between MAST4 downregulation and upregulation of chondrogenic markers

• Functional studies:

  • Generate MAST4-depleted MSCs using CRISPR/Cas9

  • Overexpress MAST4 or specific domains (e.g., MAST4-PDZ)

  • Assess effect on chondrogenic/osteogenic differentiation using:

    • Alcian blue staining

    • 3D spheroid formation assays

    • Analysis of cartilage-specific gene expression (Col2a1, Acan)

• Mechanistic investigations:

  • Chromatin immunoprecipitation (ChIP) assays to analyze Sox9 binding to chondrogenic promoters

  • Analyze Sox9 stability and phosphorylation at Serine 494

  • Investigate MAST4's interplay with TGF-β signaling using TGF-β1 treatment or inhibitors (e.g., Vactosertib)

Research has shown that MAST4 suppression by TGF-β1 leads to increased Sox9 stability by blocking MAST4-induced Sox9 serine 494 phosphorylation, ultimately enhancing chondrogenesis .

What are the critical validation steps for MAST4 antibodies?

When validating MAST4 antibodies for research applications, consider the following critical steps:

• Specificity verification:

  • Western blot showing band at expected molecular weight (~284 kDa or isoform-specific weights)

  • Positive and negative control tissues/cells with known MAST4 expression

  • Blocking peptide experiments where available

  • MAST4 knockdown or knockout cells as negative controls

• Application-specific validation:

  • For IHC: Test different fixation methods and antigen retrieval conditions

  • For IF/ICC: Verify subcellular localization (primarily cytoplasmic, with possible nucleoplasmic localization)

  • For WB: Test different lysis buffers and loading amounts

• Cross-reactivity assessment:

  • Verify species reactivity (human, mouse, rat, etc.)

  • Check for cross-reactivity with other MAST family members

Commercial antibodies undergo validation processes including specificity testing on protein arrays containing target protein plus hundreds of non-specific proteins .

How should researchers interpret discrepancies in MAST4 staining patterns?

When encountering inconsistent MAST4 staining patterns:

• Isoform considerations:

  • Multiple MAST4 isoforms exist due to alternative splicing

  • Different antibodies may target different epitopes/domains

  • Compare epitope locations between antibodies (N-terminal, C-terminal, internal domains)

• Technical variations:

  • Fixation methods significantly impact epitope accessibility

  • Different antigen retrieval protocols may reveal distinct epitopes

  • For paraffin sections, HIER pH 6.0 is typically recommended

• Biological variables:

  • MAST4 expression is regulated by signaling pathways like TGF-β

  • Expression levels decrease during chondrogenic differentiation

  • Subcellular localization may change during cell cycle or differentiation

• Antibody characteristics:

  • Polyclonal antibodies may recognize multiple epitopes

  • Monoclonal antibodies provide more consistent staining but may miss isoforms

  • Compare results from multiple antibodies targeting different regions

What controls should be included when studying MAST4 phosphorylation of target proteins?

When investigating MAST4's kinase activity and target phosphorylation:

• Essential controls:

  • Kinase-dead MAST4 mutants (e.g., MAST4 R503A, MAST4 D504A, MAST4 K506A)

  • MAST4 knockdown cells (siRNA or CRISPR/Cas9)

  • Phosphatase treatment of samples

  • Phospho-specific antibodies for target proteins (e.g., phospho-T94-Tctex-1)

• Experimental approaches:

  • In vitro kinase assays with recombinant MAST4 and substrates

  • Co-immunoprecipitation to confirm MAST4-substrate interactions

  • Site-directed mutagenesis of predicted phosphorylation sites

  • Mass spectrometry to identify phosphorylation sites

• Pathway analyses:

  • Inhibitors of upstream pathways (e.g., TGF-β inhibitor Vactosertib)

  • Activators of relevant pathways (serum readdition for ciliary resorption studies)

  • Time-course experiments to track phosphorylation dynamics

Research has demonstrated that catalytic-inactive MAST4 mutants (particularly at residues R503, D504, and K506) significantly suppress ciliary resorption and target protein phosphorylation .

How can researchers study the interaction between MAST4 and the TGF-β/Wnt signaling pathways?

Based on recent findings , researchers investigating MAST4's role in signaling pathways should consider:

• TGF-β pathway interactions:

  • Monitor MAST4 expression after TGF-β1 treatment (shows downregulation)

  • Use TGF-β receptor inhibitors (e.g., Vactosertib) to block pathway activation

  • Analyze Sox9 stability and phosphorylation as downstream readouts

  • Investigate Smad-dependent and Smad-independent pathways

• Wnt pathway analysis:

  • Examine MAST4 protein stability after Wnt pathway activation

  • Study GSK-3β-mediated regulation of MAST4

  • Investigate Smurf1 recruitment to MAST4

  • Monitor β-catenin nuclear localization and Runx2 activity as functional readouts

• Crosstalk investigation:

  • Dual pathway manipulation experiments

  • Co-immunoprecipitation of MAST4 with pathway components

  • Domain-specific mutants to dissect interaction points

Research has shown that MAST4 protein stability is enhanced by Wnt-mediated inhibition of GSK-3β and subsequent Smurf1 recruitment, which promotes β-catenin nuclear localization and Runx2 activity, ultimately increasing osteogenesis of MSCs .

What are the latest findings regarding MAST4's domain structure and how does this impact antibody selection?

MAST4 contains several functional domains that impact both its biological activity and antibody recognition:

• Domain architecture:

  • Kinase domain: Critical for phosphorylation activity, contains key residues (R503, D504, K506) essential for function

  • PDZ domain: Important for protein-protein interactions

  • AGC-kinase C-terminal domain: Regulatory function

• Antibody considerations based on domains:

  • N-terminal antibodies: Multiple commercial options target this region

  • Kinase domain-specific antibodies: Useful for functional studies

  • C-terminal antibodies: May detect specific isoforms

• Functional implications:

  • MAST4-PDZ overexpression suppresses chondrogenic differentiation

  • Mutations in kinase domain residues (R503A, D504A) create dominant-negative effects

  • Different domains may localize differently within cells

When selecting MAST4 antibodies, researchers should consider which domain they need to target based on their experimental questions and the specific isoforms relevant to their tissue/cell system.

How might MAST4 antibodies be used to develop therapeutic approaches for ciliopathies?

Research suggests MAST4 could be a potential therapeutic target for ciliopathies related to ciliary resorption defects . Researchers exploring this possibility should consider:

• Therapeutic target validation:

  • Use MAST4 antibodies to screen expression in disease models and patient samples

  • Develop phospho-specific antibodies against MAST4 substrates as biomarkers

  • Monitor MAST4 activity in ciliopathy models

• Experimental approaches:

  • High-content screening assays using MAST4 antibodies to identify modulators

  • Structure-function analysis of MAST4's kinase domain to guide inhibitor design

  • MAST4 knockdown/overexpression in ciliopathy disease models

  • Phospho-proteomics to identify the full spectrum of MAST4 substrates

• Translational considerations:

  • Development of cell-permeable kinase inhibitors targeting MAST4

  • Monitoring effects on ciliary dynamics using ciliary markers

  • Validation in multiple cell types and disease-relevant models

Research has identified MAST4 as "a potential new target for treating ciliopathies causally by ciliary resorption defects" , highlighting the importance of further studying this kinase in the context of ciliary biology and related diseases.

What are the optimal sample preparation methods for MAST4 western blotting?

For effective western blot detection of MAST4:

• Lysis considerations:

  • Complete protease inhibitor cocktails are essential

  • Phosphatase inhibitors should be included when studying phosphorylation events

  • RIPA or NP-40 based buffers are typically suitable

• Sample handling:

  • Fresh samples yield better results than frozen/thawed

  • Avoid multiple freeze-thaw cycles

  • Load adequate protein amounts (typically 20-50 μg total protein)

• Electrophoresis parameters:

  • Use lower percentage gels (6-8%) due to MAST4's high molecular weight

  • Extend transfer times for large proteins

  • Consider wet transfer methods for more efficient transfer of high MW proteins

• Detection considerations:

  • Recommended antibody dilutions typically range from 1:500 to 1:2000

  • Secondary antibody selection should match the host species (typically rabbit)

  • Enhanced chemiluminescence (ECL) detection systems work well for most applications

The observed molecular weight of MAST4 may differ from the calculated weight (284 kDa), with some antibodies detecting bands around 72 kDa , potentially representing specific isoforms or processed fragments.

What cellular and tissue models are most appropriate for studying MAST4 function?

Based on published research, the following models have proven useful for MAST4 studies:

• Cell lines:

  • RPE-1 cells: Effective for ciliary resorption studies

  • HEK293 cells: Useful for protein interaction studies and overexpression experiments

  • C3H10T1/2 murine mesenchymal stromal cells: Valuable for studying differentiation

  • ATDC5 murine chondrogenic cells: Model for chondrogenesis studies

  • A-431 cells: Human epidermoid carcinoma cell line validated for MAST4 immunofluorescence

• Primary cells:

  • Human bone marrow-derived stem cells (hBMSC): Suitable for studying MAST4's role in differentiation

  • Human primary chondrocytes: Show TGF-β1-mediated MAST4 regulation

• Tissue samples:

  • Human esophagus: Shows strong cytoplasmic MAST4 expression in squamous epithelial cells

  • Adult tissues known to express MAST4: testis, colon, and small intestine

• Experimental systems:

  • 3D spheroid culture models: Useful for differentiation studies

  • Serum starvation/readdition protocols: Effective for studying ciliary resorption dynamics

When selecting a model system, researchers should consider the specific MAST4 function they aim to study and the endogenous expression levels in their chosen system.